Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition

Daria Lizneva, Tony Yuen, Li Sun, Se min Kim, Ihor Atabiekov, Lubna Bashir Munshi, Sol Epstein, Maria New, Mone Zaidi

Research output: Contribution to journalReview articlepeer-review

36 Scopus citations

Abstract

Bone loss in women accelerates during perimenopause, and continues into old age. To-date, there has been little progress made in stratifying for fracture risk in premenopausal and early postmenopausal women. Epidemiologic data suggests that changes in serum FSH could predict decrements in bone mass during peri- and postmenopause. In bone, FSH stimulates osteoclast formation by releasing osteoclastogenic cytokines. Here, we address the evidence for bone loss across the menopausal transition, discuss strategies for detection and treatment of early postmenopausal osteoporosis, and describe the role FSH plays in physiology and likely in pathophysiology of early postmenopausal bone loss.

Original languageEnglish
Pages (from-to)70-81
Number of pages12
JournalMatrix Biology
Volume71-72
DOIs
StatePublished - Oct 2018

Keywords

  • Bone mineral density
  • Follicle-stimulating hormone
  • Menopause
  • Monoclonal antibodies
  • Osteoporosis
  • Polyclonal antibodies

Fingerprint

Dive into the research topics of 'Emerging concepts in the epidemiology, pathophysiology, and clinical care of osteoporosis across the menopausal transition'. Together they form a unique fingerprint.

Cite this